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The effect of soy protein on serum lipid profile and some lipid metabolizing enzymes in rats fed with 
cholesterol diets was examined in this study. Rats were subjected to feeding trial over a period of six 
weeks on formulated diets containing: 20% soy protein with 0% cholesterol (group A), 20% soy protein 
with 5% cholesterol (group B), 20% soy protein with 10% cholesterol (group C), 0% soy protein with 20% 
cholesterol (group D), and 5% soy protein with 20% cholesterol (group E). Serum total, VLDL, LDL, and 
HDL-cholesterol and triglyceride concentrations were found to be reduced significantly in Groups B and 
C when compared with Groups D and E (p < 0.05). The lipid profile in group C did not, however, differ 
significantly when compared to the control group (p > 0.05). Groups D and E showed significant 
increased levels (p < 0.01) when compared to other groups. Lipoprotein lipase (LPL), lecithin:cholesterol 
acyl transferase (LCAT), and triglyceride lipase (TGL) activities were found to be significantly reduced (p 
< 0.05) in groups B and C when compared with groups D and E. Though groups B, C, D, and E rats all 
showed significant elevation (p < 0.05) in the enzyme activities when compared to the control.  
 





It is well known that cardiovascular disease (CVD) is the 
leading cause of death in both men and women in 
developed countries. Hypercholesterolemia has been 
established as a primary risk factor in the development of 
CVD. Studies in this area are mostly preventive and have 
focused on ways of reducing serum cholesterol by nutri-
tional means. Preventing or reducing the increase in 
serum cholesterol is associated with reducing risk for 
CVD. Diet plays an important role in controlling blood 
lipids. Although elevation of serum or tissue cholesterol 
after excessive cholesterol intake depends on the animal 
species, cholesterol administration has been shown to 
increase total cholesterol in rats (Kummerow, 1982). The 
hypercholesterolemia that develops when animals are fed 
on high fat diet is consistently characterized by an in-
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proteins (LDL) (Vegroesen, 1972; Berg et al., 1986). The 
hypercholesterolemic effect of soy protein has been 
recognized for more than thirty years (Zhan and Ho, 
2005). Animal studies show that substituting soy protein 
for dietary animal protein reduces serum total and LDL 
cholesterol concentrations (Colacurci et al., 2005). The 
magnitude of the cholesterol lowering effect of soy pro-
tein is similar to that observed for other plant-based foods 
such as oat bran, or garlic and has been confirmed to be 
a major clinical means of treating patients with genetically 
based hypercholesterolemia (Setchell, 1998). However, 
the real potential of soy protein appears to be preventing 
the rise in serum cholesterol which is diet- induced in 
almost 40% of the adult population and therefore in 
lowering the overall risk for CVD.  
 Changes in serum lipids are controlled by those enzy-
mes responsible for lipid metabolism; Lipoprotein lipase 
(LPL) is the crucial enzyme in the metabolism of triglyce-
ride rich lipoproteins. Elevated triglyceride rich lipoprotein 
levels not only may promote a more rapid progression of 
atherosclerosis, but could also lead to  myocardial  ische-  
 
 




Table 1. Feeding regimen for each group. 
 
Group  
Feed composition A B C D E 
Maize Flour 70 65 60 70 65 
Fish Meal 10 10 10 10 10 
Soy Protein 20 20 20 - 5 
Cholesterol - 5 10 20 20 
Total 100 100 100 100 100 
Calorie Equivalent 450 475 500 510 530 
% Soy Protein incorporated 20 20 20 0 5 




mia particularly in subjects with high triglyceride/low HDL 
traits which is frequently present in coronary artery 
disease (CAD) (Nordis and Mack, 1995). Earlier reports 
have shown that sub endothelially located LPL exhibited 
proatherogenic effect by increasing oxidative suscep-
tibility of LDL facilitating the uptake of triglyceride rich 
lipoproteins by macrophages. The latter promotes foam 
cell formation which is the hallmark of atherogenesis 
(Babaev et al., 1999; Libby et al., 2002; Milosavjevic et 
al., 2003). 
 Lecithin:cholesterol acyl transferase (LCAT) is a serum 
enzyme that esterifies free cholesterol, primarily at the 
surface of the HDL particle after which the cholesteryl 
ester molecules migrate to the inner core of this lipo-
protein. Through this action, LCAT plays a key role in the 
maturation of HDL particles. In humans, almost all serum 
cholesteryl esters are formed by the activity of LCAT and 
individuals devoid of this enzyme show abnormal plasma 
lipoproteins (Glomset, 1968; Glomset et al., 1970; Nordby 
and Norum, 1975). Experimental findings have indicated 
that modification of serum proteins by LCAT alters rates 
of cholesterol flux between cells and medium and results 
in a net loss of cholesterol from the cells accompanied by 
cellular cholesterol synthesis (Glomset, 1970; Glomset, 
1976; Ray et al., 1980; Relimpio and Iriarte, 1981). 
Studies have also shown that an increased activity of 
LCAT is proatherogenic (Ononogbu and Okpara, 1986; 
Onyeneke et al., 1991). 
 High levels of serum triglyceride has been strongly 
linked with low serum HDL cholesterol (Richards et al., 
1989; Avogaro et al., 1991) and these low HDL Levels 
may contribute to increased risk for CVD (Assmann et al., 
1986). Triglyceride lipase is a major factor in the reduc-
tion of serum triglyceride concentration (Kantor et al., 
1985). 
 The enzymes; lipoprotein lipase (LPL), LCAT and 
triglyceride lipase (TGL) have been hypothesized to 
participate in the regulation of cholesterol metabolism. 
This hypothesis coupled with the effect of soy protein on 
serum lipid profile is explored in this present study. 




Matured soy beans (uncooked) were purchased from Iwaro Market, 
Oka Akoko, Ondo State, Nigeria and were identified as Glycine 
maximus (soybean) by a taxonomist in the Department of Crop 
Science, Faculty of Agriculture, University of Benin, Nigeria. This 
was ground into powder and used in the diet formulation. Some of 




Animals and diets 
 
Thirty five (35) twelve weeks old albino rats (Wister Strain) weighing 
between 60 – 70 Kg purchased from the animal house of the 
department of Biochemistry, University of Ilorin, Nigeria were used 
for the study. The rats were housed in stainless steel cages with 
raised wire floors at a temperature of 30 degrees centigrade and 
fed on rat chow and water ad libitum for a period of two weeks to 
acclimatize. The animals were then divided into five groups of 
seven rats each designated A (control), B, C, D and E (experi-
mental) were then placed on five different dietary regimen as shown 
in Table 1. Before the commencement of the dietary regimen, the 
animals were fasted overnight but allowed access to water ad 
libitum. One rat from each group was sacrificed on Day 0 and its 






At weekly intervals, one rat from each group was sacrificed and 2 
ml of blood was collected from the animal by cardiac puncture. The 
blood was allowed to stand at room temperature to clot and 
centrifuged at 10,000 g for 5 min using Hettich (Universal II) centri-
fuge to separate serum from the cells. The supernatant (serum) 
was carefully decanted and analysis was carried out immediately. 
Determination of total and free cholesterol in the serum was by the 
method of Searcy and Bergquist (1960). Serum triglyceride (TG) 
was determined using the method of Tiez (1990) after enzymatic 
hydrolysis by lipases LDL and HDL-cholesterol as well as VLDL- 
cholesterol were determined according to the methods described by 
Friedwald et al. (1972). Protein content was determined by the 
Biuret reaction described by Gornall et al. (1949) while lipoprotein 
lipase and triglyceride lipase activities were determined by the 
method of Kamimura et al.  (1999).  LCAT  activity  was  determined  
 
 




Table 2. Change in mean body weights (g) of rats fed soy protein and cholesterol diet. 
 
Mean body weight (g)  
Time on diet (weeks) A B C D E 
0 0 0 0 0 0 
1 6.58 4.13 6.90 8.68 9.00 
2 8.38 14.57 11.59 13.15 9.06 
3 18.77 19.18 22.90 19.78 19.66 
4 25.33 20.54 23.82 35.75 30.80 
5 19.29 13.89 9.54 5.56 6.19 




by the methods described by Varman and Soloff (1976). Lipoprotein 
lipase and triglyceride lipase activities were measured in mmol of 
free fatty acids liberated per minute while LCAT activity was expres-





Statistical analysis was done by one way analysis of variance 
(ANOVA) and Duncan Multiple range test (DMRT). The level of 





The animals consumed their daily rations satisfactorily 
and showed increase in their body weight. The weekly 
percentage increase in body weight for the respective 
groups is presented in Table 2. Table 3 shows the weekly 
changes in serum total, free, esterified VLDL-, LDL-, and 
HDL-cholesterol concentration observed for the respec-
tive groups over the six weeks treatment period. Results 
obtained indicated that rats in groups B and C fed 20% 
soy protein with 5 and 10% cholesterol, respectively, 
showed decreases in their serum cholesterol levels when 
compared to the control while groups D and E rats fed 
20% cholesterol with 0 and 5% soy protein, respectively, 
showed significant increases (p < 0.05, p < 0.01) in their 
serum cholesterol levels when compared to the control 
and groups B and C. Generally, the reduction in group B 
rats was statistically significant (p < 0.05) when compared 
to the control and in all the cholesterol fractions. Group E 
(5% soy protein + 20% cholesterol) rats, however, had 
reduced cholesterol fraction levels (p < 0.05) when com-
pared to group D rats (0% soy protein + 20% cholesterol). 
Table 4 shows the changes in the serum triglyceride 
concentration for the respective groups studied. Although 
there was no significant mean difference in group B and 
C rats (p > 0.05), group D rats fed 20% cholesterol 
without soy protein showed significantly elevated levels of 
serum triglyceride (p < 0.05).  
 Table 5 shows lipoprotein lipase activity (expressed in 
mmol of free fatty acid hydrolyzed per minute) for the 
respective groups over the six weeks period. Rats in 
groups B, C, D and E showed a significant increase (p < 
0.05) in their serum lipoprotein lipase activity when com-
pared to the control. The enzyme activity in group D is 
about 2-folds that of the control and inclusion of soy 
protein showed significant reduction (p < 0.05) in the 
activity of LPL when compared to group D rats. The 
esterifying activity of serum LCAT expressed as mg 
cholesterol ester formed per 100 ml serum is as shown in 
Table 6. The results obtained showed that rats in groups 
D and E fed 20% cholesterol with 0% soy protein and 5% 
soy protein, respectively, showed about 3-fold and 2.5-
fold increase in activity when compared to the control rat 
at the end of the feeding trial. Though rats in groups B, C, 
D, and E showed a significant increase (p < 0.05) in 
LCAT activity when compared with the control, and high-
er activity was observed in group D when compared with 
groups B, C and E. Table 7 shows the results obtained 
for serum triglyceride lipase (TGL) activity. Rats in group 
D showed elevated levels in serum triglyceride lipase 
(TGL) (p < 0.01) when compared to the control. The 
groups on soy protein supplementation (groups B, C and 
E) showed significant reduction (p < 0.05) in TGL levels 






Cholesterol rich diet has been demonstrated by several 
workers to increase serum total VLDL and LDL choleste-
rol as well as serum triglyceride concentrations (Berg et 
al., 1986; McGill, 1988; Onyeneke et al., 1991). Contrary 
to the expected elevation of serum total cholesterol, 
VLDL cholesterol, LDL cholesterol and triglyceride con-
centrations, the results obtained from this study show 
decreased total VLDL and LDL cholesterol as well as 
triglyceride concentrations. The results obtained for 
groups B and C rats showed reductions in their serum 
total VLDL and LDL cholesterol concentrations as well as 
triglyceride concentrations. This could be attributable to 
the inclusion of 20% soy protein in the animal diet. This 
observation is justifiable since group D rats fed  diet  con- 
 
 




Table 3. Weekly changes in serum total, free, esterified VLDL-, LDL- and HDL-cholesterol concentrations (mg/dl) of rats fed 
soy protein and cholesterol diet. 
 
Time on diet (weeks) Groups 
 A B C D E 
TC 197.0 ±2.0 .a 193.3 ±3.0 a 198.3 ±6.0 a 195.3 ±4.0 a 197.0 ±4.0 a 
VLDL – C 19.7 ±0.8 a 19.3 ±0.8 a 19.8 ±0.5 a 19.5 ±0.6 a 19.7 ±0.7 a 
LDL - C 128.3 ±3.0 a 126.0 ±4.0 a 129.0 ±4.0 a 127.0 ±2.0 a 128.0 ±3.0 a 
HDL - C 49.0 ±1.0a 48.0 ±2.0 a 49.5 ±1.0 a 48.8 ±1.0a 49.3 ±1.0 a 





CE 132.0±3.0 a 129.0±2.0 a 132.0±3.0 a 130.0±2.0 a 131.0±1.0 a 
TC 195.5 ± 3.0 a 192.2 ±1.0 a 199.0 ±3.0 b 200.0 ±4.0 b 199 .0±3.0 b 
VLDL – C 19.5 ±0.9 a 19.2 ±0.6 a 20.9 ±0.5 a 20.0 ±0.4 a 19.9 ±0.5 a 
LDL - C 127.0 ±3.0 a 125.0 ±3.0 a 129.9 ±2.0 a 130.0 ±3.0 a 129.3 ±2.0 a 
HDL - C 49.0 ±2.0 a 48.0 ±1.0 a 47.2 ±3.0 a 50.0 ±2.0 a 49.8 ±2.0 a 




EC 131.0±2.0 a 128.0±3.0 a 133.0±2.0 a 133.0±2.0 a 133.0±3.0 a 
TC 193.3 ±3.0 a 190.7 ±2.0 b 192.2 ±3.0 b 207.5 ±5.0 c 204.4 ±3.0 c 
VLDL – C 19.3 ±1.2 a 19.2 ±0.8 a 19.2 ±0.6 a 20.7 ±0.7 a 20.4 ±0.5 a 
LDL - C 126.0 ±1.0 a 124.0 ±2.0 a 125.0 ±3.0 a 135.0 ±2.0 b 133.0 ±2.0 b 
HDL - C 48.0 ±3.0 a 47.5 ±1.0 a 48.0 ±2.0 a b 51.8 ±1.0 b 51.0 ±2.0 b 




EC 129.0±1.0 a 127.0±2.0 a 128.0±3.0 a 138.0±2.0 a 136.0±2.0 a 
TC 198.8 ±2.0 a 190.9 ±3.0 b 193.5 ±3.0 b 221.7 ±4.0 c 213.9 ±5.0 d 
VLDL – C 19.8 ±0.6 a 19.1 ±0.6 a 19.3 ±0.4 a 22.2 ±0.8 b 21.0 ±0.8 b 
LDL - C 129.0 ±3.0 a 124.0 ±1.0 b 126.0±1.0ab 144.0 ±2.0 c 139.0 ±1.0 d 
HDL - C 50.0 ±3.0 a 47.8 ±0.5 a 48.2 ±1.2 a 55.5 ±0.5 b 53.5 ±1.0 b c 




EC 132.0±2.0 a 127.0±2.0 b 129.0±2.0ab 148.0±3.0 c 143.0±4.0 c 
TC 195.6 ±3.0 a 189.1 ±4.0 b 195.6 ±2.0 a 246 .1±8.0 c 229 .2±7.0 d 
VLDL – C 19.6 ±0.2 a 18.9 ±0.5 a 19.6 ±0.6 a 24.6 ±0.6 b 22.9 ±0.9 c 
LDL - C 127.0 ±2.0 a 123.0 ±2.0 b 127.0 ±1.0 a 160.0 ±3.0 c 149.0 ±1.0 d 
HDL - C 49.0 ±1.0 a 47.2 ±2.0 a 49.0 ±1.0 a 61.5 ±2.0 b 57.3 ±2.0 b 





EC 131.0±1.0 a 126.0±2.0b 131.0±2.0a 164.0±4.0 c 153.0±3.0d 
TC 198.9 ±4.0 a 189.1 ±1.0 b 196.9 ±3.0 a 253.9 ±9.0 c 237.0 ±6.0 d 
VLDL – C 19.8 ±0.1 a 18.9 ±0.4 b 19.7 ±0.3 a 25.4 ±0.7 c 23.7 ±0.5 d 
LDL - C 129.0 ±2.0 a 123.0 ±1.0 b 128.0 ±2.0 a 165.0 ±4.0 c 154.0 ±1.0 d 
HDL - C 50.0 ±1.0 a 47.2 ±2.0 a 49.2 ±0.5 a 63.5 ±1.0 b 59.3 ±1.0 c 




EC 132.0±2.0 a 126.0±1.0 b 131.0±3.0 a 169.0±5.0 c 158.0±3.0 d 
TC 198.8 ±3.0 a 187.5 ±3.0 b 195.6 ±2.0 a 267.5 ±4.0 c 258.3 ±3.0 d 
VLDL – C 19.8 ±0.3 a 18.7 ±0.5 b 19.6 ±0.4 a 26.7 ±0.5 c 25.8 ±0.6 d 
LDL - C 129.0 ±1.0 a 122.0 ±2.0 b 127.0 ±3 a 174.0 ±1.0 c 168.0 ±2.0 d 
HDL - C 50.0 ±1.0 a 46.8 ±0.5 b 49.0 ±1.0 a 66.8 ±1.0 c 64.5 ±1.0 c 




EC 132.0±1.0 a 125.0±3.0 b 131.0±2.0 a 178.0±3.0 c 172.0±3.0 c 
 
Tabulated results are means of five determinations ± SEM. Values in the same row carrying different superscripts are significantly 
different (p < 0.05). TC = Total cholesterol, VLDL-C = very low density lipoprotein cholesterol, LDL-C = low density lipoprotein 








Table 4. Serum triglyceride concentrations (mg/dl) of rats fed soy protein and cholesterol diet. 
 
Serum triglycerides concentration (mg/dl) Time on diet 
(weeks) A B C D E 
0 134 ±2 a 131 ±3 a 137 ±5 a 136 ±3 a 133 ±3 a 
1 137 ±4 a 135 ±2 a 138 ±4 a 150 ±3 b 146 ±2 b 
2 139 ±3 a 137 ±2 b 142 ±3 b 168 ±5 c 160 ±3 c 
3 138 ±2 a 141 ±2 a 140 ±3 a 189 ±4 b 181 ±3 c 
4 140 ±3 a 143 ±2 a 143 ±2 a 206 ±9 b 209 ±7 b 
5 143 ±4 a 146 ±2 a 144 ±3 a 220 ±6 b 222 ±5 b 
6 144 ±3 a 148 ±2 a 146 ±2 a 233 ±7 b 237 ±5 b 
 
Tabulated results are means of five determinations ± SEM.  




Table 5. Serum lipoprotein lipase activities (mmol/min ×10-2) of rats fed soy protein and cholesterol diet.  
 
Serum lipoprotein lipase activity (mmol/min ×10-2) Time on diet 
(weeks) A B C D E 
0 8±0.4a 9±0.8 a 8±0.5 a 8±0.3 a 9±1.0 a 
1 10±1.0 a 12±0.9b 11±0.5 b 23±2.0 c 22±2.0 c 
2 11±2.0 a 13±1.0 a 15±2.0 a 25±2.0 b 26±2.2 b 
3 14±1.4 a 20±2.0 b 21±1.3 b 32±2.0 c 30±1.4 c 
4 13±1.6 a 25±3.1 b 28±2.6 b 37±2.3 c 33±1.7 c 
5 11±0.9 a 16±0.8 b 17±1.4 b 22±1.8 c 20±2.0 c 
6 9±0.8 a 15±1.5 b 16±1.0 b 20±2.0 c 17±1.3 c 
 
Tabulated results are means of five determinations ± SEM. Values in the same row carrying different 




Table 6. Serum LCAT activities (mg cholesterol ester/100 ml serum) of rats fed soy protein and cholesterol 
diet.  
 
Serum (LCAT) activity (mg cholesterol ester/100 ml serum)  
Time on diet 
(weeks) A B C D E 
0 58.5±2.0a 58.0±2.0a 58.0±2.0a 58.0±2.0a 58.0±2.0a 
1 61.0±3.0a 93.5±3.0b 89.0±4.0b 101.5±6 .0c 115.0±4.0d 
2 58.0±6.0a 117.5±7.0b 115.5±5.0b 120.5±3.0b 118.0±2.0b 
3 57.0±1.0a 121.0±2.0b 119.0±3.0b 155.0±6.0c 137.0±3.0d 
4 58.5±2.0a 132.5±4.0b 130.0±2.0b 160.5±1.0c 152.0±2.0d 
5 60.5±1.0a 140.5±3.0b 139.5±2.0b 163.5±0.5c 154.5±1.0d 
6 61.5±0.8a 142.5±0.6b 141.0±0.3b 170.5±1.0c 157.5±0.6d 
 
Tabulated results are means of five determinations ± SEM. Values in the same row carrying different 




taining no soy protein showed significantly (p < 0.05) 
raised levels serum total cholesterol, VLDL cholesterol, 
LDL cholesterol and triglyceride concentrations, while 
group E rats fed diet containing 5% soy protein showed 
significant decrease (p < 0.05) in their serum total VLDL 
and LDL cholesterol concentrations as well as triglyceride  
 
 




Table 7. Serum triglyceride lipase activities (mmol/min x10-2) of rats fed soy protein and cholesterol diet.  
 
Serum triglyceride lipase activity (mmol/min x10-2)  
Time on diet 
(weeks) A B C D E 
0 9±0.8 a 9±1.2 a 9±0.5 a 9±1.3 a 9±0.8 a 
1 10±1.2 a 12±1.6 a 11±1.8 a 19±1.5 b 17±2.0 b 
2 12±0.6 a 17±1.9 b 15±2.0 b 25±3.1 c 21±0.7 d 
3 14±1.2 a 23±2.0 b 22±2.2 b 33±3.4 c 29±1.4 d 
4 17±2.2 a 28±1.2 b 25±2.6 b 35±1.2 c 32±2.0 c 
5 12±0.8 a 17±1.5 b 16±1.4 b 29±2.1 c 27±1.8 c 
6 11±1.2 a 13±2.0 b 13±1.6 b 24±2.2 c 22±1.3 c 
 
Tabulated results are means of five determinations ± SEM.  




concentrations when compared to group D rats. This 
results further strengthens the earlier reports on the 
hypocholesterolemic effect of soy protein (Zhan and Ho, 
2005; Colacurci et al., 2005). Comparative clinical trials 
by Anderson et al. (1995) showed that consumption of 
diets rich in soy protein as opposed to those high in 
animal protein significantly lowers blood total cholesterol 
level, LDL cholesterol and triglycerides without lowering 
helpful HDL cholesterol. Kirk et al. (1998) have also 
demonstrated that diet containing intact or unextracted 
soy protein significantly reduces lesion areas in wild type 
mice when compared to those fed phytooestrogen 
extracted soy protein. They equally observed that there 
was no difference in the extent of atherosclerosis in the 
LDL receptor deficient mice fed intact soy protein and 
those fed phytoestrogen extracted soy protein. This 
suggests that cellular LDL receptors play a significant 
role in soy protein hypocholesterolemic effect (Baum et 
al., 1998). The activities of lipid metabolizing enzymes 
especially lipoprotein lipase, LCAT and triglyceride lipase 
have been reported to be responsive to nutritional factors 
(Richards et al., 1989; Fielding and Fielding, 1980). 
Exogenous cholesterol does contribute significantly in the 
regulation of the activities of these enzymes. Hypertrigly-
ceridemia, a major risk factor for CVD has been 
demonstrated to be associated with increased LPL and 
TGL activity (Kantor et al., 1985; Richards et al., 1989; 
Patsch and Gotlo, 1995). Similarly, variation in the serum 
level of HDL cholesterol has been reportedly linked to the 
activity of LPL and TGL (Richards et al., 1989; Avogaro 
et al., 1991; Patsch and Gotlo, 1995). Low levels of HDL 
cholesterol observed in patients at high risk of CVD have 
been associated with increased LPL and TGL activities.  
The result of our present study shows that consumption 
of soy protein reduces to baseline levels, serum LPL and 
TGL activity. Earlier reports by Onyeneke et al. (1991) 
and Ononugbu et al. (1986) have demonstrated that 
increased LCAT activity is proatherogenic. The results 
obtained from this study supports this claim. This is 
justified since group D rats fed diets containing 0% soy 
protein with 20% cholesterol showed significantly higher 
LCAT activity when compared with group B and C rats 
fed 20% soy protein. The action of soy protein on the 
activity of these lipid metabolizing enzymes could be 
attributable to its hypocholesterolemic effect. Thus, 
reduction in serum levels of cholesterol and triglycerides 
may lead to a corresponding decrease in the activity of 
these enzymes. It is therefore suggested that the inclu-
sion of soy protein in the diet improves serum lipid profile 
as well as control the activities of the lipid metabolizing 
enzymes. Hence, soy protein could be beneficial in 
reducing the increased risk to and consequent death 
(resulting from intake of high fat diet) due to 
atherosclerosis. 
 The action of soy protein over the activities of these 
lipid-metabolizing enzymes could be ascribed to its hypo-
cholesterolemic attributes; thus reductions in serum 
levels of cholesterol and triglycerides may lead to a 
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